学术探索
学术期刊
新闻热点
数据分析
智能评审

Emerging anticoagulant drugs

被引：19
作者：
Bates, SM
Weitz, JI
机构：
[1] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 09期
关键词：
anticoagulant; antithrombotic; venous thromboembolism; arterial thromboembolism; direct thrombin inhibitor;
D O I：
10.1161/01.ATV.0000084827.77945.66
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
引用
收藏
页码：1491 / 1500
页数：10
相关论文
共 126 条
  • [1] Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study
    Abraham, E
    Reinhart, K
    Svoboda, P
    Seibert, A
    Olthoff, D
    Dal Nogare, A
    Postier, R
    Hempelmann, G
    Butler, T
    Martin, E
    Zwingelstein, C
    Percell, S
    Shu, V
    Leighton, A
    Creasey, AA
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (11) : 2081 - 2089
  • [2] Alderman EL, 1998, J AM COLL CARDIOL, V32, P1
  • [3] Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia
    Amiral, J
    Lormeau, JC
    MarfaingKoka, A
    Vissac, AM
    Wolf, M
    BoyerNeumann, C
    Tardy, B
    Herbert, JM
    Meyer, D
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (02) : 114 - 117
  • [4] HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL
    ANTMAN, EM
    [J]. CIRCULATION, 1994, 90 (04) : 1624 - 1630
  • [5] Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial
    Antman, EM
    [J]. CIRCULATION, 1996, 94 (05) : 911 - 921
  • [6] AOKI Y, 1994, THROMB HAEMOSTASIS, V71, P452
  • [7] Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa
    Arnljots, B
    Ezban, M
    Hedner, U
    [J]. JOURNAL OF VASCULAR SURGERY, 1997, 25 (02) : 341 - 346
  • [8] Bajaj MS, 1997, THROMB HAEMOSTASIS, V78, P471
  • [9] BAJAJ SP, 1985, J BIOL CHEM, V260, P1574
  • [10] BANNER DW, 1993, ADV EXP MED BIOL, V340, P27
12345678910